搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli O81 tRNA 2-thiocytidine biosynthesis protein TtcA (ttcA) CSB-YP484485EOP
CSB-EP484485EOP
CSB-BP484485EOP
CSB-MP484485EOP
CSB-EP484485EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 UPF0060 membrane protein ynfA (ynfA) CSB-YP484486EOP
CSB-EP484486EOP
CSB-BP484486EOP
CSB-MP484486EOP
CSB-EP484486EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Spermidine export protein MdtI (mdtI), partial CSB-YP484487EOP1
CSB-EP484487EOP1
CSB-BP484487EOP1
CSB-MP484487EOP1
CSB-EP484487EOP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Tyrosine--tRNA ligase (tyrS) CSB-YP484488EOP
CSB-EP484488EOP
CSB-BP484488EOP
CSB-MP484488EOP
CSB-EP484488EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Putative phosphotransferase ydiA (ydiA) CSB-YP484489EOP
CSB-EP484489EOP
CSB-BP484489EOP
CSB-MP484489EOP
CSB-EP484489EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Threonine--tRNA ligase (thrS) CSB-YP484490EOP
CSB-EP484490EOP
CSB-BP484490EOP
CSB-MP484490EOP
CSB-EP484490EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 N-succinylarginine dihydrolase (astB) CSB-YP484491EOP
CSB-EP484491EOP
CSB-BP484491EOP
CSB-MP484491EOP
CSB-EP484491EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 UPF0756 membrane protein YeaL (yeaL), partial CSB-YP484492EOP1
CSB-EP484492EOP1
CSB-BP484492EOP1
CSB-MP484492EOP1
CSB-EP484492EOP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 ProP effector (proQ) CSB-YP484493EOP
CSB-EP484493EOP
CSB-BP484493EOP
CSB-MP484493EOP
CSB-EP484493EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Copper homeostasis protein CutC (cutC) CSB-YP484494EOP
CSB-EP484494EOP
CSB-BP484494EOP
CSB-MP484494EOP
CSB-EP484494EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Putative mannosyl-3-phosphoglycerate phosphatase (ECED1_2221) CSB-YP484495EOP
CSB-EP484495EOP
CSB-BP484495EOP
CSB-MP484495EOP
CSB-EP484495EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Hydroxyethylthiazole kinase (thiM) CSB-YP484496EOP
CSB-EP484496EOP
CSB-BP484496EOP
CSB-MP484496EOP
CSB-EP484496EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Multidrug resistance protein MdtC (mdtC), partial CSB-YP484497EOP
CSB-EP484497EOP
CSB-BP484497EOP
CSB-MP484497EOP
CSB-EP484497EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Lipopolysaccharide core heptose (II)-phosphate phosphatase CSB-YP484498EOP
CSB-EP484498EOP
CSB-BP484498EOP
CSB-MP484498EOP
CSB-EP484498EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Cytochrome c-type biogenesis protein CcmE (ccmE), partial CSB-YP484499EOP
CSB-EP484499EOP
CSB-BP484499EOP
CSB-MP484499EOP
CSB-EP484499EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 2-keto-3-deoxy-L-rhamnonate aldolase (rhmA) CSB-YP484500EOP
CSB-EP484500EOP
CSB-BP484500EOP
CSB-MP484500EOP
CSB-EP484500EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Undecaprenyl phosphate-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase (arnT), partial CSB-YP484501EOP
CSB-EP484501EOP
CSB-BP484501EOP
CSB-MP484501EOP
CSB-EP484501EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 NADH-quinone oxidoreductase subunit K (nuoK), partial CSB-YP484502EOP1
CSB-EP484502EOP1
CSB-BP484502EOP1
CSB-MP484502EOP1
CSB-EP484502EOP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Chorismate synthase (aroC) CSB-YP484503EOP
CSB-EP484503EOP
CSB-BP484503EOP
CSB-MP484503EOP
CSB-EP484503EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 tRNA (guanine-N (1)-)-methyltransferase CSB-YP484504EOP
CSB-EP484504EOP
CSB-BP484504EOP
CSB-MP484504EOP
CSB-EP484504EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>